Scientists target HIV's brain hideout with common arthritis pill
NCT ID NCT05452564
Summary
This study is testing if baricitinib, an existing drug for rheumatoid arthritis, can reduce the amount of hidden HIV virus in the brain and spinal fluid. It involves 95 adults whose HIV is well-controlled with standard medication. Researchers will compare the drug to a placebo, using spinal taps, blood tests, brain scans, and memory tests to see if it helps clear the virus from the nervous system.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emory University Hospital
RECRUITINGAtlanta, Georgia, 30322, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Grady Memorial Hospital
RECRUITINGAtlanta, Georgia, 30303, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.